Skip to content
Review

COVID-19 Vaccination in Children: A Global Perspective

Aug 2026 · Journal of Health Management · 0 citations · 28 references

TL;DR

A review was planned to review policy-level factors determining starting COVID-19 vaccination among children, taking into account their lower biological reserve and their being less likely to follow the non-pharmacological interventions.

Abstract

Vaccines are an important way to manage infectious diseases worldwide. In the current COVID-19 pandemic, various vaccines are being prepared and approved for use. Many countries have approved these vaccines for use among the paediatric population. The vaccines have some side effects in the adult population, and some side effects were also found in the paediatric population in different trials, although they are very rare. The paediatric population is also one of the important age groups, taking into account their lower biological reserve and their being less likely to follow the non-pharmacological interventions. In the current scenario of poor vaccination coverage in adults, is it justified to vaccinate the paediatric age group? Thus, the current review was planned to review policy-level factors determining starting COVID-19 vaccination among children.

View source

Similar papers

Review Open access Sep 2026

Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults.

Seasonal influenza and SARS-CoV-2 are respiratory viruses that represent a global health concern, causing substantial numbers of hospitalizations and mortality, particularly among high-risk groups, including infants and older adults. Together these associated respiratory diseases and related complications are among the...

W. Schaffner, S. Gravenstein, S. Kissler et al. · 0 citations
Conference Open access 2025

THE IMPACT OF THE COVID-19 PANDEMIC ON VACCINATION COVERAGE WITH THE MMR VACCINE

. Introduction. Rubella is a viral disease caused by the rubella virus. Together with measles and varicella, it belongs to the group of febrile rashes. Although the clinical course is mild in both children and adults, infection during pregnancy can lead to serious congenital malformations in the fetus. The consequences...

Jasmina M. Jovanović Mirković, Marija S. Jovanović, Christos G. Alexopoulos et al. · 0 citations
Review Sep 2026

Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Technical Report.

This technical report accompanies the American Academy of Pediatrics policy statement recommendations for COVID-19 vaccination during the 2026-2027 respiratory virus season. The rationale is presented for recommending vaccination in all infants and children 6 through 23 months of age, children 6 months through 18 years...

Unknown authors · 1 citation
Open access Aug 2026

Immunogenicity of COVID-19 Vaccines in Patients Under Immunosuppressive Therapy: Insights Into Antibody Response and Gender Differences

While most ARD patients demonstrated a detectable response, gender appeared to influence antibody levels, with females exhibiting a weaker response, which is consistent with the literature suggesting that vaccine efficacy may be reduced in immunocompromised populations.

Reza Farrokhseresht, Hanieh Roghanian, H. Samimagham et al. · 0 citations
Review Sep 2026

COVID-19 Vaccination Burden in Asia

Coronavirus disease 2019 (COVID-19) pandemic had severely impacted the global economies and posed an additional and unwanted burden on their healthcare systems. However, very limited research has been conducted to evaluate the pharmacoeconomic burden of COVID-19 pandemic and COVID-19 vaccination programs in Asian count...

M. S. Iqbal · 0 citations
Open access Aug 2026

Long-term adverse effects following COVID-19 vaccination

During the COVID-19 pandemic, vaccinations were highly beneficial to public health, preventing disease and reducing mortality. This study aimed to investigate long-term adverse clinical symptoms following COVID-19 vaccination with the Oxford AstraZeneca (ChAdOx1 nCoV-19, Oxford), Pfizer-BioNTech (BNT162b2), and Moderna...

J. Aldali, S. Meo · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.